Ginsenoside Rg1 Protects Against Ischemic/Reperfusion-Induced Neuronal Injury Through miR-144/Nrf2/ARE Pathway

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/s41401-018-0154-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Salidroside Protects Against MPP+-Induced Neuronal Injury Through DJ-1-Nrf2 Antioxidant Pathway

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2017English

Ischemic Postconditioning Protects Against Global Cerebral Ischemia/Reperfusion-Induced Injury in Rats

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2008English

Combined Salvianolic Acid B and Ginsenoside Rg1 Exerts Cardioprotection Against Ischemia/Reperfusion Injury in Rats

PLoS ONE
Multidisciplinary
2015English

Gastrodin Protects Against LPS-induced Acute Lung Injury by Activating Nrf2 Signaling Pathway

Oncotarget
Oncology
2017English

Ischemic Postconditioning-Mediated miRNA-21 Protects Against Cardiac Ischemia/Reperfusion Injury via PTEN/Akt Pathway

PLoS ONE
Multidisciplinary
2013English

Co-Enzyme Q10 Protects Rat Heart Against Oxidative Stress Induced by Ischemic Reperfusion Injury

International Journal of Biological Chemistry
BiochemistryPharmacology
2010English

LncRNA MALAT1 Silencing Protects Against Cerebral Ischemia-Reperfusion Injury Through miR-145 to Regulate AQP4

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2020English

Astaxanthin Protects OTA-Induced Lung Injury in Mice Through the Nrf2/NF-κB Pathway

Toxins
MutagenesisToxicologyHealth
2019English

Chinese Herbal Medicine Xinji Pill Protects the Heart From Ischemia/Reperfusion Injury Through the Akt/Nrf2 Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy